Single-Use Harmonization Needs A Tune Up

The single-use systems (SUS) takeover isn’t coming — it’s already here. Yet, despite widespread adoption and maturing SUS technologies, a surprising lack of standardization persists across the industry. The lack of standards has a far-reaching impact on both suppliers and end users of SUS, affecting implementation, life cycle management, and interchangeability. This exposes production to risks like supply chain disruptions, tech transfer delays, and costly workarounds.

In this on-demand event, experts Frank Gillam, Ph.D., Director of MSAT at Locus Biosciences, Mark Petrich, Ph.D., VP of Technical Operations at Krystal Biotech, and SUS Consultant Paul Priebe explore this issue and propose actionable steps forward for the industry. They discuss where biopharma can benefit the most from SUS standardization and how the industry can pursue harmonization without sacrificing flexibility. This Bioprocess Online Live event is hosted by Tyler Menichiello and is free to watch thanks to the event sponsor, CPC.